Association of the M1VPRKAR1AMutation with Primary Pigmented Nodular Adrenocortical Disease in Two Large Families
Open Access
- 1 January 2010
- journal article
- case report
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (1) , 338-342
Abstract
Background: Carney complex (CNC) is a familial multiple neoplasia syndrome frequently associated with primary pigmented nodular adrenocortical disease (PPNAD), a bilateral form of micronodular adrenal hyperplasia that leads to Cushing’s syndrome (CS). Germline PRKAR1A mutations cause CNC and only rarely isolated PPNAD. Patients and Methods:PRKAR1A mutation analysis in two large families with CS and no other CNC manifestations demonstrated a M1V germline mutation; a total of 21 asymptomatic individuals were screened, and mutation carriers were evaluated for CNC. The mutation was expressed in vitro and functionally tested for its effects on protein kinase A function. Results: Presymptomatic testing identified five first-degree relatives who were M1V carriers and who were all diagnosed with subclinical, mild CS at ages ranging from 20–56 yr. There were no other signs of CNC. In a cell-free system, we detected a shorter compared with the wild-type type 1α regulatory subunit of protein kinase A (PRKAR1A) protein (43 kDa). This was not identified in cell lines from the patients or in transfection experiments in HEK293 cells that showed no detectable PRKAR1A protein from the M1V-bearing constructs. In these cells, the mutant mRNA was expressed in a 1:1 ratio. Conclusion: In two large families, the M1V PRKAR1A mutation resulted in a PPNAD-only phenotype with significant variability both in terms of age of onset and clinical severity. Expression studies showed a unique effect of this sequence change. This study has implications for genetic counseling of carriers of this PRKAR1A mutation and patients with CNC and PPNAD and for the study of PRKAR1A-related tumorigenesis.Keywords
This publication has 22 references indexed in Scilit:
- Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different GenotypesThe Journal of Clinical Endocrinology & Metabolism, 2009
- A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesionsJournal of Medical Genetics, 2004
- Molecular Analysis of the Cyclic AMP-Dependent Protein Kinase A (PKA) Regulatory Subunit 1A (PRKAR1A) Gene in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease (PPNAD) Reveals Novel Mutations and Clues For Pathophysiology: Augmented PKA Signaling is Associated with Adrenal Tumorigenesis in PPNADThe American Journal of Human Genetics, 2002
- Mutations of thePRKAR1AGene in Cushing’s Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2002
- Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient EvaluationThe Journal of Clinical Endocrinology & Metabolism, 2001
- Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complexNature Genetics, 2000
- Proteasomal Degradation of Unassembled Mutant Type I Collagen Pro-α1(I) ChainsJournal of Biological Chemistry, 1999
- Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6The EMBO Journal, 1997
- Carney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomasSeminars in Dermatology, 1995
- Suprarenal tumor (Cushing's syndrome)The Journal of Pediatrics, 1957